After confirming the protective effects of IHMT-MST1-39 on β cells, we next conducted the experiments in vivo using the MLD-STZ induced T1D mouse model to evaluate the effects of IHMT-MST1-39 treatment. The gene discussed is MST1; the disease is type 1 diabetes mellitus.